Evolus is a global performance beauty company redefining the aesthetic injectable market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Its mission is to become a global leader in aesthetics anchored by its flagship products: Jeuveau (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics, and Evolysse, a collection of unique injectable hyaluronic acid (HA) gels. Visit www.evolus.com, and follow on LinkedIn, X, Instagram or Facebook.